Testing effectiveness (Phase 2)Ended earlyNCT01554176
What this trial is testing
Safety and Efficacy of MK-6096 as Adjunctive Therapy in Participants With Major Depressive Disorder And Partial Response to Antidepressant Monotherapy (MK-6096-022)
Who this might be right for
Major Depressive Disorder, Recurrent
Merck Sharp & Dohme LLC 129